ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT

J.F.R. Robertson; S.E. Come; S.E. Jones; L. Beex; M. Kaufmann; A. Makris; J.W.R. Nortier; K. Possinger; L.-E. Rutqvist

Tumors of female reproductive system
Opuholi ženskoj reproduktivnoj sistemy

ISSN 1994-4098 (Print)
ISSN 1999-8627 (Online)

User

eng | рус

Tumors of female reproductive system

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Robertson J., Come S., Jones S., Beex L., Kaufmann M., Makris A., Nortier J., Possinger K., Rutqvist L. ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT. Tumors of female reproductive system. 2008;(1):33-40. (In Russ.) https://doi.org/10.17650/1994-4098-2008-0-1-33-40

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1994-4098 (Print)
ISSN 1999-8627 (Online)

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Editor-in-Chief

Semiglazov Vladimir F.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

J.F.R. Robertson
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

S.E. Come
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

S.E. Jones
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

L. Beex
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

M. Kaufmann
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

A. Makris
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

J.W.R. Nortier
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

K. Possinger
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

L.-E. Rutqvist
Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Beth Israel Deaconess Medical Center, Boston, MA, USA; Charles A. Sammons Cancer Center, Dallas, TX, USA; University Medical Centre Nijmegen, Nijmegen, The Netherlands; Goethe University, Frankfurt, Germany; Academic Oncology Unit, Mount Vernon Hospital, Middlesex, UK; Leiden University Medical Center, Leiden, The Netherlands; Humboldt University Berlin, Berlin, Germany; Karolinska Institute, Stockholm, Sweden
Russian Federation

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Tumors of female reproductive system

For citations:

Cookies policy